2016 Annual Review

2016 Annual Review Our 2016 Annual Review (with 2015/2016 financials) is now available to view online. In less than seven years, the Snowdome Foundation has extended 24 grants representing over $14 million to Australian researchers and almost 80% of Snowdome’s available funds have been fast-tracked into cutting-edge medical research.  Importantly, we have been able to deliver … Continued

New addition to the Snowdome Foundation Executive team

New addition to the Snowdome Foundation Executive team The Snowdome Foundation is thrilled to introduce Suzie Bratuskins as a passionate and invaluable member of the Snowdome Foundation. Suzie will work to engage our stakeholders to share the wonderful work Snowdome is currently achieving in blood cancer research. Suzie Bratuskins has seamlessly transitioned into her role … Continued

Snowdome co-founder, Professor Miles Prince publishes a paper on impressive new research

Snowdome co-founder, Professor Miles Prince publishes a paper on impressive new research The Snowdome Foundation is proud to announce that blood cancer specialist, researcher and co-founder of Snowdome, Professor Miles Prince, has published a paper in The Lancet reporting on the outcome of the ALCANZA study, an international, randomised, open-label Phase 3 trial of brentuximab … Continued

The ‘Bloody Good Dinner’

What a Bloody Good Success! Last year, we celebrated the outstanding achievement and collaboration of Snowdome Foundation and Maddie Riewoldt’s Vision via winning the National Charity Telstra Business Awards. To continue and strengthen this partnership, the Snowdome Foundation and Maddie Riewoldt’s Vision joined forces to create the ‘Bloody Good Dinner’. Hosted at Melbourne’s historic Meat … Continued

New Fellowship award – Dr Jake Shortt

We are delighted to report that Dr Jake Shortt (pictured second from left with Snowdome CEO, Miriam Dexter, the Hon. David Davis and Snowdome Director, Nicky Long) has been awarded the Eva and Les Erdi / Snowdome Foundation Fellowship for New Targets in Haematological Malignancies. The announcement was made recently at a Victorian Cancer Agency … Continued